Month: April 2023
-
Biotech, Undersea Researchers Partner on Carbon Capture Bacteria
A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide.
-
New Funds to Invest in Digital Health Start-Ups
A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses.
-
Taking a Break
We’ll resume our regular posts on Tuesday, 18 Apr.
-
Biotech, Dairy Company Collaborate on Plant-Based Cheese
A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese.
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
Biotech Group Blasts Reproductive Drug Ruling
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.”
-
Infographic – Q1 2023 Venture Funds Hunker Down
While venture investment dollars worldwide edged higher in the first three months of 2023, the number of deals continued to slide from the previous quarter.
-
Health, Tech Venture Investor Adds $850M Fund
A venture capital company specializing in early-stage investments in life science, health, and technology start-ups announced a new $850 million fund.
-
Seaweed Biomaterials Start-Up Gains $5M in Early Funds
A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round.
-
Trial Okayed for Glaucoma Treatment Implant
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma.